MedTrace Logo

Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer

NCT02324127 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100

Last updated 2014-12-24

No results posted yet for this study

Summary

Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases.

Conditions

Interventions

DEVICE

hsp90

Detect plasma Hsp90α concentration of lung cancer patients

Sponsors & Collaborators

  • Protgen Ltd

    lead INDUSTRY

Principal Investigators

  • Shusen Zhen, MD · The first hospital of Zhejiang province

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324127 on ClinicalTrials.gov